| abstract |
Provided is a low dose IL-2 therapy for an autoimmune disease, immune related disease or inflammatory disease, including inflammation in a human subject. A method of reducing or preventing an undesirable immune response in a human subject, effective in stimulating regulatory T lymphocytes (Treg) and substantially inducing effector T lymphocytes (Teff) A method comprising administering to the subject an uninteresting amount of interleukin-2 (IL-2). [Selection figure] None |